| PubMed |
Abstract |
RScore(About this table) |
| 19762159 |
Gomez-Gil E, Navines R, Martinez De Osaba MJ, Diaz-Ricart M, Escolar G, Salamero M, Martin-Santos R, Galan A, Gasto C: Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. Psychoneuroendocrinology. 2010 May;35(4):481-9. Epub 2009 Sep 16.
|
6(0,0,0,6) |
Details |
| 16035959 |
Rossi DV, Valdez M, Gould GG, Hensler JG: Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. Int J Neuropsychopharmacol. 2006 Aug;9(4):393-406. Epub 2005 Jul 22.
We evaluated, using quantitative autoradiography, the effect of these antidepressant treatments on [35S] GTPgammaS binding stimulated by the 5-HT1A receptor agonist 8-OH-DPAT, a measure of the capacity of 5-HT1A receptors to activate G proteins. |
2(0,0,0,2) |
Details |
| 12422559 |
Bourin M, David DJ, Jolliet P, Gardier A: [Mechanism of action of antidepressants and therapeutic perspectives] . Therapie. 2002 Jul-Aug;57(4):385-96.
Behavioural, electrophysiological and microdialysis studies have shown that serotonin (5-HT) receptors, mainly 5-HT1A, 5-HT1B and 5-HT2C sub-types, exert a key role in modulating antidepressant activity. |
2(0,0,0,2) |
Details |